Cognitive impairment networks in Alzheimer's disease: Analysis of three double-blind randomized, placebo-controlled, clinical trials of donepezil

[1]  Eiko I. Fried,et al.  Network analysis of multivariate data in psychological science , 2021, Nature Reviews Methods Primers.

[2]  Sacha Epskamp,et al.  How to Compare Psychometric Factor and Network Models , 2020, Journal of Intelligence.

[3]  N. Herrmann,et al.  Questioning the Meaning of a Change on the Alzheimer’s Disease Assessment Scale–Cognitive Subscale (ADAS-Cog): Noncomparable Scores and Item-Specific Effects Over Time , 2020, Assessment.

[4]  A. Rotstein.  Network analysis of the structure and change in the mini-mental state examination: a nationally representative sample , 2020, Social Psychiatry and Psychiatric Epidemiology.

[5]  2020 Alzheimer's disease facts and figures , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[6]  P. Tariot,et al.  Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease , 2019, The New England journal of medicine.

[7]  H.L.J. van der Maas,et al.  Extending psychometric network analysis: Empirical evidence against g in favor of mutualism? , 2019, Intelligence.

[8]  M. Montero‐Odasso,et al.  The Alzheimer’s Disease Assessment Scale–Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review , 2018, Journal of Alzheimer's disease : JAD.

[9]  C. Jack,et al.  Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers , 2017, The Lancet Neurology.

[10]  D. Borsboom.  A network theory of mental disorders , 2017, World psychiatry : official journal of the World Psychiatric Association.

[11]  S. Leucht,et al.  Identifying a system of predominant negative symptoms: Network analysis of three randomized clinical trials , 2016, Schizophrenia Research.

[12]  S. Levine,et al.  Network analysis of the Quick Inventory of Depressive Symptomatology: Reanalysis of the STAR*D clinical trial , 2016, European Neuropsychopharmacology.

[13]  Joseph H. Grochowalski,et al.  Examining the reliability of ADAS-Cog change scores , 2016, Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition.

[14]  Eiko I. Fried,et al.  Estimating psychological networks and their accuracy: A tutorial paper , 2016, Behavior Research Methods.

[15]  D. Borsboom,et al.  Network analysis: an integrative approach to the structure of psychopathology. , 2013, Annual review of clinical psychology.

[16]  Verena D. Schmittmann,et al.  Qgraph: Network visualizations of relationships in psychometric data , 2012 .

[17]  R. Ihl,et al.  Detecting treatment effects with combinations of the ADAS‐cog items in patients with mild and moderate Alzheimer's disease , 2012, International journal of geriatric psychiatry.

[18]  J. Hobart,et al.  The ADAS-cog in Alzheimer's disease clinical trials: psychometric evaluation of the sum and its parts , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[19]  Frank Tennigkeit,et al.  Review of Alzheimer's disease scales: is there a need for a new multi-domain scale for therapy evaluation in medical practice? , 2010, Alzheimer's Research & Therapy.

[20]  John Skvoretz,et al.  Node centrality in weighted networks: Generalizing degree and shortest paths , 2010, Soc. Networks.

[21]  Mark Newman,et al.  Networks: An Introduction , 2010 .

[22]  J. Sevigny,et al.  Review: Item Analysis of ADAS-Cog: Effect of Baseline Cognitive Impairment in a Clinical AD Trial , 2010, American journal of Alzheimer's disease and other dementias.

[23]  Lisa Geraci,et al.  How Well Do the ADAS-cog and its Subscales Measure Cognitive Dysfunction in Alzheimer’s Disease? , 2009, Dementia and Geriatric Cognitive Disorders.

[24]  Daniel L. Rubin,et al.  Network Analysis of Intrinsic Functional Brain Connectivity in Alzheimer's Disease , 2008, PLoS Comput. Biol..

[25]  C. Stam,et al.  Small-world networks and functional connectivity in Alzheimer's disease. , 2006, Cerebral cortex.

[26]  K. Hasegawa,et al.  Clinical Efficacy and Safety of Donepezil on Cognitive and Global Function in Patients with Alzheimer’s Disease , 2000, Dementia and Geriatric Cognitive Disorders.

[27]  H.-J. Möller,et al.  The Effects of Donepezil in Alzheimer’s Disease – Results from a Multinational Trial1 , 1999, Dementia and Geriatric Cognitive Disorders.

[28]  R. Mohs,et al.  A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease , 1998, Neurology.

[29]  R. Ihl,et al.  Alzheimer's Disease Assessment Scale: Reliability and Validity in a Multicenter Clinical Trial , 1997, International Psychogeriatrics.

[30]  L. Schneider,et al.  Assessing response to tacrine using the factor analytic structure of the Alzheimer's disease assessment scale (Adas)—cognitive subscale , 1995 .

[31]  D. Knopman,et al.  The Clinician Interview‐ Based Impression (CIBI) , 1994, Neurology.

[32]  Edward M. Reingold,et al.  Graph drawing by force‐directed placement , 1991, Softw. Pract. Exp..

[33]  H. Buschke,et al.  Cued recall in amnesia. , 1984, Journal of clinical neuropsychology.

[34]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[35]  C. Jack,et al.  Framework : Towards a Biological Definition of Alzheimer ’ s Disease 1 2 draft 9-19-17 3 4 5 , 2017 .

[36]  R. Mohs,et al.  Alzheimer's Disease Assessment Scale (ADAS). , 1988, Psychopharmacology bulletin.

[37]  Matthieu Latapy,et al.  Computing Communities in Large Networks Using Random Walks , 2004, J. Graph Algorithms Appl..